nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors
|
van Ommen-Nijhof, Annemiek |
|
|
196 |
3 |
p. 591-602 |
artikel |
2 |
A population health assessment of screening mammography on breast cancer mortality in North Carolina
|
Burch, Ashley E. |
|
|
196 |
3 |
p. 647-656 |
artikel |
3 |
Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors
|
Freedman, Rachel A. |
|
|
196 |
3 |
p. 623-633 |
artikel |
4 |
Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center
|
Shafi, Saba |
|
|
196 |
3 |
p. 463-469 |
artikel |
5 |
Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma
|
Moreno, Gustavo A. |
|
|
196 |
3 |
p. 453-461 |
artikel |
6 |
Epidemiology of interstitial lung disease in patients with metastatic breast cancer at baseline and after treatment with HER2-directed therapy: a real-world data analysis
|
Law, Jeanna Wallenta |
|
|
196 |
3 |
p. 603-611 |
artikel |
7 |
Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer
|
Verma, Neha |
|
|
196 |
3 |
p. 535-547 |
artikel |
8 |
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane
|
Pohlmann, Paula R. |
|
|
196 |
3 |
p. 571-581 |
artikel |
9 |
High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy
|
Cha, Eumee |
|
|
196 |
3 |
p. 517-525 |
artikel |
10 |
Intrinsic subtypes in Ethiopian breast cancer patient
|
Desalegn, Zelalem |
|
|
196 |
3 |
p. 495-504 |
artikel |
11 |
Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study
|
Zheng, Qiufan |
|
|
196 |
3 |
p. 613-622 |
artikel |
12 |
Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer
|
Lobanova, Olga |
|
|
196 |
3 |
p. 505-515 |
artikel |
13 |
Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis
|
Brown, Lauren |
|
|
196 |
3 |
p. 441-451 |
artikel |
14 |
Oncologic safety of axillary lymph node dissection with immediate lymphatic reconstruction
|
Guzzo, Hope M. |
|
|
196 |
3 |
p. 657-664 |
artikel |
15 |
Patient-centered dosing: oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC)
|
Loeser, Anne L. |
|
|
196 |
3 |
p. 549-563 |
artikel |
16 |
Patterns of breast cancer second recurrences in patients after mastectomy
|
Lim, Geok Hoon |
|
|
196 |
3 |
p. 583-589 |
artikel |
17 |
PIK3CA-mutations in breast cancer
|
Reinhardt, Kristin |
|
|
196 |
3 |
p. 483-493 |
artikel |
18 |
Prognosis and effectiveness of chemotherapy for medullary breast carcinoma
|
Aihara, Tomohiko |
|
|
196 |
3 |
p. 635-645 |
artikel |
19 |
Retraction Note to: Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression
|
Liang, Zhongxing |
|
|
196 |
3 |
p. 665 |
artikel |
20 |
The effect of delay of excisional biopsy on upstage rate for atypical ductal hyperplasia, flat epithelial atypia, intraductal papilloma, and radial scar
|
Casaubon, Jesse |
|
|
196 |
3 |
p. 527-534 |
artikel |
21 |
Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of age
|
Williams, Austin D. |
|
|
196 |
3 |
p. 565-570 |
artikel |
22 |
Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation
|
Vihervuori, H. |
|
|
196 |
3 |
p. 471-482 |
artikel |